Amdipharm Mercury - AMCo. - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Amdipharm Mercury - AMCo. M&A Summary

Amdipharm Mercury - AMCo. has acquired 3 companies of its own. A total of 1 acquisition came from private equity firms.

Amdipharm Mercury - AMCo.’s largest acquisition to date was in 2010, when it acquired Focus Pharmaceuticals for $77M. Amdipharm Mercury - AMCo. has acquired in 3 countries. The Company’s most targeted sectors include life science (67%) and medical products (34%).

Amdipharm Mercury - AMCo. Ownership

Who owns Amdipharm Mercury - AMCo.?

Amdipharm Mercury - AMCo. is owned by ADVANZ PHARMA. It was acquired on September 8, 2015.

Was Amdipharm Mercury - AMCo. formerly PE-backed?

Yes. Amdipharm Mercury - AMCo. was formerly owned by 1 private investor.

Amdipharm Mercury - AMCo. Business Overview

Where is Amdipharm Mercury - AMCo. headquartered?

Amdipharm Mercury - AMCo. is headquartered in Croydon, United Kingdom.

What sector is Amdipharm Mercury - AMCo. in?

Amdipharm Mercury - AMCo. is a life science company.

M&A Summary

  • M&A Total Activity3
    • M&A Buy Activity3
  • Total Sectors Invested 2
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 1

Amdipharm Mercury Co., Ltd. - AMCo.

No 1 Croydon, 12-16 Addiscombe Road,
Croydon, CR0 0XT
United Kingdom,
+44 (0) 208 588 9100
www.amcolimited.com

Amdipharm Mercury (AMCo) is an international speciality pharmaceuticals company delivering high quality medicines with a customer focus in 112 territories.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 3 - - - - - 3
vol $77M $77M
Sell (0.0/yr) # - - - - - - 0
  3

Most Recent M&A

Company Date Value Type
Boucher & Muir Pty Ltd. 2015-07-14 - Add-on Acquisition
Crows Nest, Australia · www.bnmgroup.com
Abcur AB 2013-12-06 - Add-on Acquisition
, Sweden · www.abcur.se
Focus Pharmaceuticals Ltd. 2010-10-01 77M GBP Add-on Acquisition
London, United Kingdom · www.focuspharmaceuticals.co.uk
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 2 (67%) 77M (100%) - -
Medical Products 1 (33%) - - -
Total 3 $77M - -

By Geo

State/Country Buy Value Sell Value
Australia 1 - - -
Sweden 1 - - -
United Kingdom 1 77M - -
Domestic 1 (33%) 77M (100%) - -
Cross-border 2 (67%) - - -
Total 3 $77M - -

Deal Values

buy # Total
< $100M 1 $77M
TOTAL $77M
Largest Focus Pharmaceuticals Ltd.
$77M (2010-10-01)

M&A Connections

Deals
Acquired from
Investor(s)
33%
1 (33%)

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Amdipharm Mercury - AMCo.

Life Science Companies , United Kingdom Companies